siRNA

AbbVie pays ADARx $335M cash for next-gen siRNA options
Fierce Biotech
Wed, 05/14/25 - 11:20 am
AbbVie
ADARx Pharmaceuticals
siRNA
funding
Sirus Therapeutics announces positive signals from Phase I siRNA trial
Clinical Trials Arena
Tue, 12/10/24 - 11:11 am
Sirus Therapeutics
clinical terials
siRNA
SRSD107
myocardial infarction
ischemic stroke
Lilly, Insitro Ink Unique AI Deal, Eye Novel Treatments for Metabolic Diseases
BioSpace
Wed, 10/9/24 - 09:46 am
Insitro
Eli Lilly
siRNA
MASH
Rona Therapeutics gains Series A+ funds for siRNA pipeline expansion
Pharmaceutical Technology
Sun, 07/21/24 - 11:04 pm
Rona Therapeutics
funding
siRNA
AstraZeneca & Aptamer partner to bolster targeted siRNA therapies
Clinical Trials Arena
Mon, 07/8/24 - 11:33 am
AstraZeneca
Aptamer Group
siRNA
Silence breaks down phase 1 data on blood disorder prospect, sharing glimpse at pitch for competitive niche
Fierce Biotech
Thu, 06/27/24 - 10:11 pm
Silence Therapeutics
polycythemia vera
clinical trial
siRNA
divesiran
New ‘One-And-Done’ Vaccine Method Could Protect Infants—From Covid, Flu—With Just A Single Shot, Study Suggests
Forbes
Mon, 04/15/24 - 09:35 pm
vaccines
universal vaccines
infants
siRNA
Boehringer bets $2B in biobucks to unlock siRNA targets for NASH treatments
Fierce Biotech
Wed, 01/3/24 - 09:40 am
Boehringer Ingelheim
biobucks
NASH
siRNA
Suzhou Ribo
Ribocure
AHA: One dose of Lilly’s siRNA drug cuts Lp(a) for a year
Pharmaphorum
Mon, 11/13/23 - 10:03 am
Eli Lilly
AHA
siRNA
lipoprotein(a)
cardiovascular disease
lepodisiran
Agios and Alnylam sign agreement for siRNA candidate
Pharmaceutical Business Review
Fri, 08/4/23 - 12:09 pm
Agios Pharmaceuticals
Alnylam
siRNA
polycythemia vera
Aligos culls another hepatitis B asset, citing inconclusive efficacy data
Fierce Biotech
Fri, 08/4/23 - 10:12 am
Algios Therapeutics
hepatitis B
siRNA
Novartis buys a preclinical biotech and its RNA drug technology
BioPharma Dive
Mon, 07/17/23 - 07:07 pm
Novartis
DTxPharma
siRNA
M&A
Medicxi backs siRNA-focused Aldena Therapeutics with $30M
Endpoints
Thu, 03/16/23 - 09:32 am
Aldena Therapeutics
Medicxi
siRNA
dermatology
Low-profile startup stakes its claim to Sanofi's siRNA platform in wake of setbacks
Endpoints
Mon, 07/25/22 - 10:37 am
siRNA
China
Sanofi
Rona Therapeutics
With Alzheimer's in its sights, Alnylam shares data on getting siRNA to targets beyond the liver
Fierce Pharma
Tue, 06/7/22 - 09:59 am
Alnylam
siRNA
Alzheimer's disease
drug development
Silence Therapeutics, Hansoh partner to develop novel siRNA therapeutics
Pharmaceutical Business Review
Mon, 10/18/21 - 11:06 am
Silence Therapeutics
Hansoh Pharmaceutical
mRNAi
siRNA
drug development
Novartis looks to manufacturing investment to drive down cost of siRNA drug
Biopharma Reporter
Mon, 08/9/21 - 11:01 am
Novartis
Leqvio
drug manufacturing
siRNA
inclisiran
Silence Therapeutics Says Collaborating With Astrazeneca On siRNA Therapeutics
Reuters
Wed, 03/25/20 - 10:34 am
Silence Therapeutics
AstraZeneca
siRNA
drug development
cardiovascular disease
renal disease
respiratory disease
metabolic disorders
Alnylam, Vir team up to develop siRNAs to tackle COVID-19
Fierce Biotech
Wed, 03/4/20 - 10:52 am
Alnylam
Vir Biotechnology
RNAi
coronaviruses
COVID-19
siRNA
Sylentis' dry eye drug misses primary goals in phase 3
Fierce Biotech
Thu, 01/31/19 - 11:55 pm
Sylentis
dry eye disease
PharmaMar
siRNA
tivanisiran
clinical trials

Pages